To identify the potential signaling pathways linking to the upregulation of ZFAS1 in response to sorafenib in sorafenib-resistant HCC cells, the RNA-sequencing data (Table S1) were further analyzed, using the WebGestalt for cancer hallmark enrichment [24,25]. The gene discussed is ZFAS1; the disease is hepatocellular carcinoma.